SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7
Open Access
- 1 July 2020
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 111 (7), 2349-2360
- https://doi.org/10.1111/cas.14502
Abstract
Solute carrier family 12 member 5 (SLC12A5) has an oncogenic role in bladder urothelial carcinoma. The present study aimed to characterize the molecular mechanisms of SLC12A5 in bladder urothelial carcinoma pathogenesis. Functional assays identified that in bladder urothelial carcinoma SLC12A5 interacts with and stabilizes SOX18, and then upregulates matrix metalloproteinase 7 (MMP7). In vivo and in vitro assays were performed to confirm the effect of SLC12A5's interaction with SOX18 on MMP7-mediated bladder urothelial carcinoma progression. SLC12A5 was upregulated in human bladder tumors, and correlated with the poor survival of patients with bladder urothelial carcinoma tumor invasion and metastasis, promoted by SLC12A5 overexpression. We demonstrated that SLC12A5 interacted with SOX18, and then upregulated MMP7, thus enhancing tumor progression. Importantly, SLC12A5 expression correlated positively with SOX18 and MMP7 expression in bladder urothelial carcinoma. Furthermore, SLC12A5 expression was suppressed by miR-133a-3p. Ectopic expression of SLC12A5 partly abolished miR-133a-3p-mediated suppression of cell migration. SLC12A5-SOX18 complex-mediated upregulation on MMP7 was important in bladder urothelial carcinoma progression. The miR-133a-3p/SLC12A5/SOX18/MMP7 signaling axis was critical for progression, and provided an effective therapeutic approach against bladder urothelial carcinoma.Funding Information
- National Natural Science Foundation of China (81802556)
This publication has 31 references indexed in Scilit:
- Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancerGut, 2014
- Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencingCell Research, 2014
- Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinomaCellular Oncology, 2013
- The causes and consequences of genetic heterogeneity in cancer evolutionNature, 2013
- The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell FateCell Stem Cell, 2013
- High Expression of H3K27me3 Is an Independent Predictor of Worse Outcome in Patients with Urothelial Carcinoma of Bladder Treated with Radical CystectomyBioMed Research International, 2013
- MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancerScandinavian Journal of Urology, 2012
- The Transcription Factor SOX18 Regulates the Expression of Matrix Metalloproteinase 7 and Guidance Molecules in Human Endothelial CellsPLOS ONE, 2012
- The potassium–chloride cotransporter 2 promotes cervical cancer cell migration and invasion by an ion transport‐independent mechanismJournal Of Physiology-London, 2011
- Identification of novel microRNA targets based on microRNA signatures in bladder cancerInternational Journal of Cancer, 2009